Bausch + Lomb Current Ratio 2021-2025 | BLCO
Bausch + Lomb current ratio from 2021 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Bausch + Lomb Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $2.69B | $1.73B | 1.56 |
| 2024-12-31 | $2.79B | $1.74B | 1.60 |
| 2024-09-30 | $2.83B | $1.80B | 1.57 |
| 2024-06-30 | $2.77B | $1.68B | 1.65 |
| 2024-03-31 | $2.74B | $1.62B | 1.70 |
| 2023-12-31 | $2.74B | $1.58B | 1.74 |
| 2023-09-30 | $2.46B | $1.39B | 1.78 |
| 2023-06-30 | $2.32B | $1.33B | 1.75 |
| 2023-03-31 | $2.18B | $1.25B | 1.74 |
| 2022-12-31 | $2.14B | $1.30B | 1.65 |
| 2022-09-30 | $1.86B | $1.20B | 1.55 |
| 2022-06-30 | $2.00B | $1.27B | 1.57 |
| 2022-03-31 | $1.72B | $1.09B | 1.57 |
| 2021-12-31 | $1.64B | $1.10B | 1.49 |
| 2021-09-30 | $0.00B | 0.00 | |
| 2021-06-30 | $0.00B | 0.00 | |
| 2021-03-31 | $0.00B | 0.00 | |
| 2020-12-31 | $1.65B | $0.91B | 1.82 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $4.047B | $4.791B |
| Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.426B | 25.40 |
| Elevance Health (ELV) | United States | $85.189B | 10.99 |
| CVS Health (CVS) | United States | $80.455B | 10.00 |
| Cencora (COR) | United States | $56.610B | 19.69 |
| DiDi Global (DIDIY) | China | $22.073B | 33.50 |
| Natera (NTRA) | United States | $21.942B | 0.00 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.094B | 0.00 |
| Solventum (SOLV) | United States | $12.651B | 13.39 |
| CochLear (CHEOY) | Australia | $11.541B | 0.00 |
| Revvity (RVTY) | United States | $10.528B | 18.12 |
| ICON (ICLR) | Ireland | $10.410B | 9.68 |
| Viatris (VTRS) | United States | $10.199B | 3.50 |
| Doximity (DOCS) | United States | $9.673B | 44.78 |
| HealthEquity (HQY) | United States | $8.893B | 43.75 |
| Avantor (AVTR) | United States | $8.831B | 12.83 |
| Medpace Holdings (MEDP) | United States | $8.560B | 22.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.409B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.633B | 13.00 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.170B | 38.60 |
| Sotera Health (SHC) | United States | $3.460B | 19.66 |
| Alignment Healthcare (ALHC) | United States | $3.069B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.998B | 38.98 |
| Concentras Parent (CON) | United States | $2.754B | 15.92 |
| Organon (OGN) | United States | $2.405B | 2.56 |
| GeneDx Holdings (WGS) | United States | $2.115B | 81.46 |
| Ardent Health Partners (ARDT) | United States | $2.061B | 8.79 |
| Premier (PINC) | United States | $1.882B | 14.29 |
| Progyny (PGNY) | United States | $1.860B | 40.94 |
| PACS (PACS) | United States | $1.495B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.364B | 27.29 |
| Teladoc Health (TDOC) | United States | $1.205B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.163B | 8.85 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.982B | 0.00 | |
| CareDx (CDNA) | United States | $0.951B | 14.85 |
| Nutex Health (NUTX) | United States | $0.935B | 14.13 |
| Agilon Health (AGL) | United States | $0.931B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.777B | 7.28 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.611B | 4.11 |
| LifeMD (LFMD) | United States | $0.584B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.528B | 0.00 |
| Enhabit (EHAB) | United States | $0.525B | 43.21 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| Sonida Senior Living (SNDA) | United States | $0.457B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.290B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.247B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.128B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| OncoCyte (OCX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.041B | 0.00 |
| ModivCare (MODV) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |